serw-MX  [xml]  

 DeCS Categories

D01 Inorganic Chemicals .
D01.524 Magnesium Compounds .
D01.524.550 Magnesium Sulfate .
D01.875 Sulfur Compounds .
D01.875.800 Sulfur Acids .
D01.875.800.800 Sulfuric Acids .
D01.875.800.800.850 Sulfates .
D01.875.800.800.850.500 Magnesium Sulfate .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.742 Pyrimidines .
D03.383.742.175 Dipyridamole .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.103 Benzimidazoles .
D03.633.100.103.732 Pimozide .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.124 Alkylating Agents .
D27.505.519.124.035 Antineoplastic Agents, Alkylating .
D27.505.519.562 Membrane Transport Modulators .
D27.505.519.562.500 Potassium Channel Blockers .
D27.505.954 Therapeutic Uses .
D27.505.954.248 Antineoplastic Agents .
D27.505.954.248.150 Antineoplastic Agents, Alkylating .
D27.505.954.411 Cardiovascular Agents .
D27.505.954.411.645 Potassium Channel Blockers .
D27.888 Toxic Actions .
D27.888.569 Noxae .
D27.888.569.035 Alkylating Agents .
D27.888.569.035.035 Antineoplastic Agents, Alkylating .
 Synonyms & Historicals
Dipyridamole .
Antistenocardin .
Apo-Dipyridamole .
Cerebrovase .
Cléridium .
Curantil .
Curantyl .
Dipyramidole .
Kurantil .
Miosen .
Novo-Dipiradol .
Persantin .
Persantine .
Apo Dipyridamole .
Novo Dipiradol .
A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) .
Antineoplastic Agents, Alkylating .
Alkylating Antineoplastic Agents .
Alkylating Antineoplastic Drugs .
Alkylating Antineoplastics .
Alkylating Drugs, Antineoplastic .
Antineoplastic Alkylating Agents .
Antineoplastic Drugs, Alkylating .
Antineoplastics, Alkylating .
Antineoplastic Alkylating Drugs .
Drugs, Antineoplastic Alkylating .
Alkylating Agents, Antineoplastic .
A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) .
Magnesium Sulfate .
Magnesium Sulfate, Heptahydrate .
Heptahydrate Magnesium Sulfate .
Sulfate, Magnesium .
A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083) .
Pimozide .
Antalon .
Orap 8338 .
Orap forte .
R-6238 .
R6238 .
A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) .
Potassium Channel Blockers .
Blockers, Potassium Channel .
Channel Blockers, Potassium .
A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. .